DKFZp667G2110 inhibitors refer to a class of chemical compounds that target and inhibit the activity of the protein or enzyme coded by the gene DKFZp667G2110. This gene may be involved in various cellular processes, such as signal transduction, protein-protein interactions, or cellular metabolism. Inhibitors targeting this particular gene are designed to block or reduce the activity of the corresponding protein, which may influence key intracellular pathways. These compounds are often developed through extensive screening and optimization processes to ensure that they specifically target the protein with minimal off-target effects. The chemical structure of DKFZp667G2110 inhibitors can vary, but they are generally designed to fit into the active site of the protein or interact with specific regulatory domains, preventing it from carrying out its function.
The development of DKFZp667G2110 inhibitors often involves detailed studies of the protein's three-dimensional structure, enabling researchers to design molecules that can effectively bind to the protein. These inhibitors can range from small molecules to larger, more complex compounds. The mechanism of inhibition can be either competitive, non-competitive, or allosteric, depending on how the inhibitor interacts with the protein. In competitive inhibition, the inhibitor mimics the natural substrate and competes for binding at the active site. Non-competitive inhibitors bind elsewhere on the protein, altering its function indirectly. Allosteric inhibitors bind to a site other than the active site, causing a conformational change that reduces the protein's activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural compound known for its anti-inflammatory and antioxidant properties, potentially affecting protein expression and stability, including those similar to crystallin domains. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
An Hsp90 inhibitor, which could influence the stability and function of various proteins, potentially including CRYBG3 by modulating chaperone-mediated folding. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
Another Hsp90 inhibitor, potentially affecting the stability and function of client proteins, possibly including those with crystallin domains. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can affect protein turnover and degradation, potentially influencing the levels of proteins like CRYBG3. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A natural polyphenol with antioxidant properties, known to modulate protein expression and potentially impact proteins with crystallin domains. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
A compound known to inhibit the proteasome and alter protein expression, possibly affecting proteins similar to CRYBG3. | ||||||